JP2002255604A - Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened body - Google Patents
Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened bodyInfo
- Publication number
- JP2002255604A JP2002255604A JP2001054272A JP2001054272A JP2002255604A JP 2002255604 A JP2002255604 A JP 2002255604A JP 2001054272 A JP2001054272 A JP 2001054272A JP 2001054272 A JP2001054272 A JP 2001054272A JP 2002255604 A JP2002255604 A JP 2002255604A
- Authority
- JP
- Japan
- Prior art keywords
- calcium phosphate
- cement
- phosphate
- hardened body
- high strength
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】この発明は、口腔外科を含む
医科の分野で生体骨補強治療に用いられ、高強度硬化体
の形成が可能なリン酸カルシウムセメントに関するもの
である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a calcium phosphate cement which can be used for augmentation of a living body in the field of medicine including oral surgery and can form a high-strength hardened body.
【0002】[0002]
【従来の技術】一般に、生体骨補強治療用セメントに
は、(1)硬化用水溶液を加えてスラリー化したスラリ
ーが凝固する凝結性、(2)凝固体が水分の存在下で硬
化する硬化性、(3)治療補強骨の運動を可能ならしめ
るに十分な硬化体強度、(4)硬化体が生体骨に再生す
る吸収置換性、などの特性を具備することが要求される
が、これらの特性を具備するセメントとして、従来各種
の生体骨補強治療用セメントが提案されている。2. Description of the Related Art Generally, a cement for living bone augmentation treatment includes (1) a setting property in which a slurry obtained by adding an aqueous solution for hardening is solidified, and (2) a setting property in which a solidified substance hardens in the presence of moisture. It is required that the cured body has properties such as (3) strength of the cured body sufficient to enable the movement of the treatment reinforcing bone, and (4) absorption and replacement properties of the cured body to be regenerated into living bone. As a cement having characteristics, various types of cement for augmenting and treating a living body have been proposed.
【0003】[0003]
【発明が解決しようとする課題】一方、生体にとって硬
化体は異物であることから、できるだけ少ない硬化体使
用量で治療補強骨に所定量の強度が得られるのが望まし
いが、従来提案されている生体骨補強治療用セメントに
おいては、硬化体に十分な高強度が得られないために、
治療補強骨としての硬化体の使用量の低減化を満足に図
ることができず、このため硬化体の一段の強度向上が可
能な生体骨補強治療用セメントの開発が強く求められて
いる。On the other hand, since the hardened body is a foreign substance to the living body, it is desirable that a predetermined amount of strength can be obtained in the treatment reinforcing bone with the use of the hardened body as little as possible. In living bone augmentation treatment cement, because hardened body does not have sufficient high strength,
It has not been possible to satisfactorily reduce the amount of the hardened body used as a treatment reinforcing bone, and therefore there is a strong demand for the development of a cement for living body augmentation treatment capable of further improving the strength of the hardened body.
【0004】[0004]
【課題を解決するための手段】そこで、本発明者らは、
上述の観点から、硬化体の強度向上が可能な生体骨補強
治療用セメントを開発すべく研究を行った結果、従来提
案されている各種の生体骨補強治療用セメントのうちの
リン酸カルシウムセメント、すなわち、質量%で(以
下、%は質量%を示す)、第2リン酸カルシウム:3〜
25%、α型第3リン酸カルシウムおよび不可避不純
物:残り、からなる配合組成を有する混合組成物で構成
されたリン酸カルシウムセメントに特定し、このリン酸
カルシウムセメントに、リン酸マグネシウムを0.03
〜1.5%の割合で配合してなる混合組成物をリン酸カ
ルシウムセメントとして用いると、これの適用に際し
て、これに硬化性水溶液を加えて形成したペーストの流
動性が前記リン酸マグネシウムの作用で一段と向上し、
当然の結果として気泡の巻き込みが著しく低減されるよ
うになることから、緻密な硬化体の形成が可能となり、
形成された硬化体の強度は著しく向上したものになると
いう研究結果を得たのである。Means for Solving the Problems Accordingly, the present inventors have:
In view of the above, as a result of conducting research to develop a living bone augmentation treatment cement capable of improving the strength of the cured body, calcium phosphate cement among various conventionally proposed biological bone augmentation treatment cements, that is, In mass% (hereinafter,% indicates mass%), dibasic calcium phosphate: 3 to
25%, α-type tribasic calcium phosphate and unavoidable impurities: specified as a calcium phosphate cement composed of a mixed composition having the remaining composition, and magnesium phosphate was added to the calcium phosphate cement in an amount of 0.03%.
When a mixed composition prepared at a ratio of about 1.5% is used as a calcium phosphate cement, the fluidity of a paste formed by adding a curable aqueous solution thereto is further increased by the action of the magnesium phosphate. Improve,
Naturally, the entrapment of air bubbles is significantly reduced, so that a dense cured body can be formed,
The research result showed that the strength of the formed cured product was significantly improved.
【0005】この発明は、上記の研究結果に基づいてな
されたものであって、リン酸マグネシウム:0.03〜
1.5%,第2リン酸カルシウム:3〜25%、α型第
3リン酸カルシウムおよび不可避不純物:残り、からな
る配合組成を有する混合組成物で構成してなる、高強度
硬化体の形成が可能な生体骨補強治療用リン酸カルシウ
ムセメントに特徴を有するものである。[0005] The present invention has been made based on the above research results, and contains magnesium phosphate: 0.03 to
A living body capable of forming a high-strength cured body, comprising a mixed composition having a composition of 1.5%, dibasic calcium phosphate: 3 to 25%, α-type tribasic calcium phosphate and inevitable impurities: remaining. It is characterized by a calcium phosphate cement for bone reinforcement treatment.
【0006】つぎに、この発明の生体骨補強治療用リン
酸カルシウムセメント(以下、単に本発明セメントとい
う)において、配合組成を上記の通りに限定した理由を
説明する。 (a)リン酸マグネシウム この成分には、上記の通りセメントの適用に際して、ペ
ーストの流動性を向上させ、もって気泡の巻き込みを著
しく抑制して、緻密な硬化体の形成を可能にし、この結
果硬化体の強度向上に寄与する作用があり、この作用を
十分に発揮させるためには、本発明セメントの製造に際
して、構成成分である第2リン酸カルシウムと予め混練
した状態で、残りの構成成分であるα型第3リン酸カル
シウムと配合する必要があるが、その割合が0.03%
未満では前記作用に所望の効果が得られず、一方その割
合が1.5%を越えると硬化体の硬化に要する時間が急
激に長時間化するようになることから、その割合を0.
03〜1.5%、望ましくは0.1〜1.0%と定め
た。Next, the reason for limiting the composition of the calcium phosphate cement for bone augmentation treatment of the present invention (hereinafter simply referred to as the cement of the present invention) as described above will be described. (A) Magnesium phosphate This component improves the fluidity of the paste during the application of cement as described above, thereby significantly suppressing the entrapment of air bubbles, enabling the formation of a dense cured body, and as a result, It has an effect that contributes to the improvement of the strength of the body, and in order to sufficiently exhibit this effect, in the production of the cement of the present invention, the remaining component α Although it is necessary to mix with the type tribasic calcium phosphate, the ratio is 0.03%
If the ratio is less than 1.5%, the desired effect cannot be obtained. On the other hand, if the ratio exceeds 1.5%, the time required for hardening the cured product increases sharply.
03-1.5%, desirably 0.1-1.0%.
【0007】(b)第2リン酸カルシウム この成分には、ペーストの硬化体への凝結を促進する作
用があるが、その割合が3%未満では所望の凝結促進作
用を確保することができず、一方その割合が25%を越
えると、硬化が著しく促進されるようになり、作業性が
損なわれることから、その割合を3〜25%、望ましく
は6〜20%と定めた。なお、本発明セメントの硬化性
水溶液としては、通常実用に供されている硬化性水溶
液、例えばコハク酸2ナトリウムやコンドロイチン硫酸
ナトリウム、さらに乳酸ナトリウム、リン酸ナトリウ
ム、塩化ナトリウム、亜硫酸水素ナトリウム、およびピ
ロ亜硫酸ナトリウムなどのうちの1種または2種以上を
所定量配合含有させた水溶液、並びに蒸留水などを適用
できる。(B) Dibasic calcium phosphate This component has the effect of accelerating the setting of the paste into the cured product, but if its proportion is less than 3%, the desired effect of accelerating the setting cannot be ensured. If the proportion exceeds 25%, the curing is remarkably accelerated, and the workability is impaired. Therefore, the proportion is set to 3 to 25%, preferably 6 to 20%. Examples of the curable aqueous solution of the cement of the present invention include curable aqueous solutions usually used in practice, for example, disodium succinate and sodium chondroitin sulfate, and also sodium lactate, sodium phosphate, sodium chloride, sodium bisulfite, and pyrocarbonate. An aqueous solution containing a predetermined amount of one or more of sodium sulfite and the like, and distilled water can be used.
【0008】[0008]
【発明の実施の態様】つぎに、本発明セメントを実施例
により具体的に説明する。まず、本発明セメントの構成
成分であるα型第3リン酸カルシウムとして、以下の工
程、すなわち、水酸化カルシウム:3モルを水:10リ
ットルに懸濁させ、これにリン酸:2モルを水で希釈し
てなる40%リン酸水溶液を攪拌しながらゆっくり滴下
し、滴下終了後、室温に1日間放置し、ついで乾燥機を
用い、110℃に24時間保持の条件で乾燥して凝集体
とし、引き続いて前記凝集体を1400℃に3時間保持
して焼成し、焼成生成物を粉砕し、篩分にて篩目で88
μm以下(平均粒径:6.5μm)とすることにより調
製した純度:99.9%のα型第3リン酸カルシウム粉
末を用い、リン酸マグネシウムおよび第2リン酸カルシ
ウムはそれぞれ市販の粉末を使用した。Next, the cement of the present invention will be specifically described with reference to examples. First, as the α-type tribasic calcium phosphate which is a constituent component of the cement of the present invention, the following steps, ie, 3 mol of calcium hydroxide are suspended in 10 l of water, and 2 mol of phosphoric acid is diluted with water. The resulting 40% phosphoric acid aqueous solution was slowly added dropwise with stirring. After completion of the addition, the mixture was allowed to stand at room temperature for 1 day, and then dried using a dryer at 110 ° C. for 24 hours to form aggregates. The agglomerate is held at 1400 ° C. for 3 hours and fired, and the fired product is pulverized and sieved with a sieve by 88 sieves.
α-type tribasic calcium phosphate powder having a purity of 99.9% prepared by adjusting the particle size to μm or less (average particle size: 6.5 μm) was used, and commercially available powders of magnesium phosphate and dicalcium phosphate were used.
【0009】まず、これら原料粉末のうちのリン酸マグ
ネシウム粉末と第2リン酸カルシウム粉末を、予め表1
に示される全体割合に相当する割合で混練機で30分間
十分に混練しておき、この混練粉末にα型第3リン酸カ
ルシウム粉末を表1に示される配合割合に配合し、混合
して配合割合と実質的に同じ配合組成を有する混合組成
物とすることにより本発明セメント1〜15、およびリ
ン酸マグネシウムの配合がない従来セメント1〜8をそ
れぞれ製造した。First, magnesium phosphate powder and dicalcium phosphate powder among these raw material powders were previously prepared as shown in Table 1.
Is sufficiently kneaded with a kneader for 30 minutes at a ratio corresponding to the total ratio shown in Table 1, and the α-type tricalcium phosphate powder is mixed with the kneaded powder in the mixing ratio shown in Table 1, and mixed to obtain a mixing ratio. The cements 1 to 15 of the present invention and the conventional cements 1 to 8 without the addition of magnesium phosphate were produced by using mixed compositions having substantially the same composition.
【0010】さらに、上記本発明セメント1〜15およ
び従来セメント1〜8から形成された硬化体の強度を評
価する目的で、これらセメントに、それぞれコンドロイ
チン硫酸ナトリウム:5%、コハク酸2ナトリウム・6
水和物:15%、亜硫酸水素ナトリウム:0.3%を含
有し、残りが水からなる硬化用水溶液を、質量比で、セ
メント:硬化用水溶液=3:1の割合で加え、練和して
スラリーとし、このスラリーを凝結させて直径:6mm
×高さ:12mmの寸法の円柱状凝固体とし、この凝固
体を、Na+:142.0mM、K+:5.0mM、Mg
2+:1.5mM、Ca2+:2.5mM、Cl-:14
8.8mM、HCO3 -:4.2mM、HPO4 2―:1.
0mMを含有する水溶液(疑似体液)中に5日間浸漬し
て硬化させ、この5日間の硬化処理後の硬化体の圧縮強
度を測定した。この測定結果を同じく表1に示した。Further, for the purpose of evaluating the strength of the hardened bodies formed from the cements 1 to 15 of the present invention and the cements 1 to 8 of the prior art, these cements were each provided with sodium chondroitin sulfate: 5% and disodium succinate / 6.
A hardening aqueous solution containing hydrate: 15%, sodium bisulfite: 0.3%, and the remainder consisting of water was added at a mass ratio of cement: hardening aqueous solution = 3: 1 and kneaded. Into a slurry, and condense this slurry to a diameter of 6 mm.
× height: a cylindrical solidified body dimensions of 12 mm, the solidified body, Na +: 142.0mM, K + : 5.0mM, Mg
2+ : 1.5 mM, Ca 2+ : 2.5 mM, Cl − : 14
8.8 mM, HCO 3 − : 4.2 mM, HPO 4 2− : 1.
It was immersed and cured in an aqueous solution (simulated body fluid) containing 0 mM for 5 days, and the compressive strength of the cured product after the curing treatment for 5 days was measured. The measurement results are also shown in Table 1.
【0011】[0011]
【表1】 [Table 1]
【0012】[0012]
【発明の効果】表1に示される結果から、混合組成物に
リン酸マグネシウムを配合した本発明セメント1〜15
は、これより成形された硬化体が前記リン酸マグネシウ
ムの配合がない従来セメント1〜8より形成された硬化
体に比して一段と高い強度をもつことが明らかである。
上述の通り、本発明セメントは、高強度を有する硬化体
の成形を可能とするものであり、治療補強骨の強度向上
に大いに寄与するほか、硬化体使用量の低減を図ること
ができるなど工業上有用な特性を有するものである。From the results shown in Table 1, the cements 1 to 15 of the present invention in which magnesium phosphate was blended into the mixed composition were used.
It is evident that the hardened body molded from this has a much higher strength than the hardened body formed from the conventional cements 1 to 8 which do not contain the magnesium phosphate.
As described above, the cement of the present invention enables the formation of a hardened body having a high strength, and greatly contributes to the improvement of the strength of a therapeutic reinforcing bone, and can reduce the amount of a hardened body used in industrial applications. They have useful properties.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 浅岡 伸之 埼玉県秩父郡横瀬町大字横瀬2270番地 三 菱マテリアル株式会社医用材料センター内 Fターム(参考) 4C081 AB04 AB06 CF012 CF022 CF24 DA11 DA13 4C089 AA06 AA13 BA16 CA03 CA07 ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Nobuyuki Asaoka 2270 Yokoze, Yokoze-cho, Chichibu-gun, Saitama F-term in the Medical Materials Center, Mitsubishi Materials Corporation 4C081 AB04 AB06 CF012 CF022 CF24 DA11 DA13 4C089 AA06 AA13 BA16 CA03 CA07
Claims (1)
からなる配合組成を有する混合組成物で構成したことを
特徴とする高強度硬化体の形成が可能な生体骨補強治療
用リン酸カルシウムセメント。1. mass%, magnesium phosphate: 0.03 to 1.5%, dibasic calcium phosphate: 3 to 25%, α-type tribasic calcium phosphate and inevitable impurities: remaining,
A calcium phosphate cement for bone augmentation and treatment of a living body capable of forming a high-strength cured product, characterized by comprising a mixed composition having a composition of:
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001054272A JP4111419B2 (en) | 2001-02-28 | 2001-02-28 | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body |
AU2001274506A AU2001274506A1 (en) | 2000-07-19 | 2001-06-13 | Calcium phosphate cement |
DE60137931T DE60137931D1 (en) | 2000-07-19 | 2001-06-13 | CALCIUM PHOSPHATE CEMENT |
EP01941022A EP1302453B1 (en) | 2000-07-19 | 2001-06-13 | Calcium phosphate cement |
TW090114342A TW548253B (en) | 2000-07-19 | 2001-06-13 | Calcium phosphate cement for bone reinforcing treatment capable of forming high strength cured matter |
ES01941022T ES2321583T3 (en) | 2000-07-19 | 2001-06-13 | CALCIUM PHOSPHATE CEMENT. |
AT01941022T ATE425129T1 (en) | 2000-07-19 | 2001-06-13 | CALCIUM PHOSPHATE CEMENT |
PCT/JP2001/004996 WO2002006179A1 (en) | 2000-07-19 | 2001-06-13 | Calcium phosphate cement |
HK03107461.2A HK1055289A1 (en) | 2000-07-19 | 2003-10-15 | Calcium phosphate cement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001054272A JP4111419B2 (en) | 2001-02-28 | 2001-02-28 | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002255604A true JP2002255604A (en) | 2002-09-11 |
JP4111419B2 JP4111419B2 (en) | 2008-07-02 |
Family
ID=18914632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001054272A Expired - Lifetime JP4111419B2 (en) | 2000-07-19 | 2001-02-28 | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4111419B2 (en) |
-
2001
- 2001-02-28 JP JP2001054272A patent/JP4111419B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4111419B2 (en) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06321515A (en) | High-strength hardenable material | |
JP2002000718A (en) | Calcium phosphate cement for reinforcing and curing bio-bone capable of forming high strength hardened body | |
JP4111418B2 (en) | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body | |
JP2002255604A (en) | Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened body | |
JP2002255607A (en) | Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened body | |
JP2002255610A (en) | Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened body | |
JP4111422B2 (en) | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body | |
JP4111420B2 (en) | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body | |
JP4111421B2 (en) | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body | |
JP2002255609A (en) | Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened body | |
JP2003020261A (en) | Rapidly hardenable calcium phosphate cement for reinforcement treatment for living body bone capable of forming high strength hardened body | |
WO2002068358A1 (en) | Calcium phosphate cement | |
JP2003010311A (en) | Fast-curing calcium phosphate cement for reinforcing and treating organic bone capable of forming high- strength cured body | |
JP2002035106A (en) | Calcium phosphate cement for bone reinforcing treatment capable of forming high strength cured matter | |
JP2003010307A (en) | Fast-curing calcium phosphate cement for reinforcing and treating organic bone capable of forming high- strength cured body | |
EP1302453B1 (en) | Calcium phosphate cement | |
JP2002253664A (en) | Calcium phosphate cement for reinforcing treatment of living body bone capable of forming high strength cured body | |
WO2002068357A1 (en) | Calcium phosphate cement | |
JPH06172007A (en) | High-strength cement of calcium phosphate | |
JPH0753204A (en) | Calcium phosphate-based self-hardenable composition | |
JP5777141B2 (en) | Composition and method for producing bone or tooth filler using the same | |
JP2000169199A (en) | Quick-hardening calcium phosphate cement | |
JP2021164636A (en) | Lyophilized cement, and method for producing the same | |
WO2023119704A1 (en) | Curable calcium phosphate composition, cured body manufacturing method, and cured body | |
JP3024405B2 (en) | Fast-setting calcium phosphate cement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040909 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041028 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20050112 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080404 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080404 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4111419 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110418 Year of fee payment: 3 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20080424 |
|
A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A072 Effective date: 20080826 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120418 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130418 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140418 Year of fee payment: 6 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |